Leptospirosis is associated with markedly increased triglycerides and small dense low-density lipoprotein and decreased high-density lipoprotein

Lipids

Volumn 46, Issue 10, 2011, Pages 953-960

  Gazi, Irene F ^a   Apostolou, Fotini A ^a   Liberopoulos, Evangelos N ^a   Filippatos, Theodosios D ^a   Tellis, Constantinos C ^b   Elisaf, Moses S ^a   Tselepis, Alexandros D ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Cytokines; LDL Particle size; Leptospira; Lipids; Lipoproteins; sdLDL

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE 1; CHOLESTEROL ESTER TRANSFER PROTEIN; CYTOKINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPASE A2; TRIACYLGLYCEROL;

ACUTE DISEASE; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; LIPOPROTEIN BLOOD LEVEL; MALE; PARTICLE SIZE; PROTEIN HYDROLYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADULT; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CYTOKINES; FEMALE; HUMANS; LEPTOSPIROSIS; LIPOPROTEINS; MALE; MIDDLE AGED; TRIGLYCERIDES;

LEPTOSPIRA; LEPTOSPIRA INTERROGANS;

EID: 80054808423     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-011-3580-y     Document Type: Article

References (44)

1. P Vijayachari AP Sugunan AN Shriram 2008 Leptospirosis: an emerging global public health problem J Biosci 33 557 569 19208981 10.1007/s12038-008- 0074-z 1:STN:280:DC%2BD1M7jt1Onsw%3D%3D
2. W Khovidhunkit MS Kim RA Memon JK Shigenaga AH Moser KR Feingold, et al. 2004 Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host J Lipid Res 45 1169 1196 15102878 10.1194/jlr.R300019-JLR200 1:CAS:528:DC%2BD2cXltFyqs78%3D (Pubitemid 38802622)
3. IF Gazi V Tsimihodimos AD Tselepis M Elisaf DP Mikhailidis 2007 Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles Expert Opin Biol Ther 7 53 72 17150019 10.1517/14712598.7.1.53 1:CAS:528:DC%2BD28Xht1OntLjO (Pubitemid 46091576)
4. F Apostolou IF Gazi K Lagos CC Tellis AD Tselepis EN Liberopoulos, et al. 2010 Acute infection with Epstein-Barr virus is associated with atherogenic lipid changes Atherosclerosis 212 607 613 20594556 10.1016/j.atherosclerosis. 2010.06.006 1:CAS:528:DC%2BC3cXht1Ogur%2FF
5. S Badiou C Merle De Boever AM Dupuy V Baillat JP Cristol J Reynes 2003 Decrease in LDL size in HIV-positive adults before and after lopinavir/ritonavir-containing regimen: an index of atherogenicity? Atherosclerosis 168 107 113 12732393 10.1016/S0021-9150(03)00058-3 1:CAS:528:DC%2BD3sXjsVerurY%3D (Pubitemid 36555817)
6. ML Rufail HA Schenkein SE Barbour JG Tew R van Antwerpen 2005 Altered lipoprotein subclass distribution and PAF-AH activity in subjects with generalized aggressive periodontitis J Lipid Res 46 2752 2760 16179738 10.1194/jlr.M500389-JLR200 1:CAS:528:DC%2BD2MXhtlWmsb7L (Pubitemid 43107488)
7. F Apostolou IF Gazi A Kostoula CC Tellis AD Tselepis M Elisaf, et al. 2009 Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella J Lipid Res 50 2532 2539 19535817 10.1194/jlr.P900063- JLR200 1:CAS:528:DC%2BD1MXhsVyrsbzI
8. I Ikonomidis CA Michalakeas J Lekakis J Parissis M Anastasiou-Nana 2011 The role of lipoprotein-associated phospholipase A2 (Lp-PLA2) in cardiovascular disease Rev Recent Clin Trials 6 108 113 21241231 10.2174/157488711795177903 1:CAS:528:DC%2BC3MXmsVCntrw%3D
9. I Gazi ES Lourida T Filippatos V Tsimihodimos M Elisaf AD Tselepis 2005 Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma Clin Chem 51 2264 2273 16223884 10.1373/clinchem. 2005.058404 1:CAS:528:DC%2BD2MXht1yks7fK (Pubitemid 41692569)
10. CC Tellis AD Tselepis 2009 The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma Biochim Biophys Acta 1791 327 338 19272461 1:CAS:528:DC%2BD1MXltVCrsrY%3D
11. RA Memon J Fuller AH Moser KR Feingold C Grunfeld 1999 In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response Am J Physiol 277 R94 R103 10409262 1:CAS:528:DyaK1MXkslKmsLk%3D (Pubitemid 29356782)
12. F Trimoreau B Francois A Desachy A Besse P Vignon Y Denizot 2000 Platelet-activating factor acetylhydrolase and haemophagocytosis in the sepsis syndrome Mediators Inflamm 9 197 200 11132779 10.1080/09629350020002921 1:CAS:528:DC%2BD3cXptVamu70%3D
13. W Khovidhunkit RA Memon JK Shigenaga M Pang M Schambelan K Mulligan, et al. 1999 Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome Metabolism 48 1524 1531 10599983 10.1016/S0026-0495(99)90240-8 1:CAS:528:DyaK1MXnvFKlsr8%3D
14. MI Mackness B Mackness PN Durrington 2002 Paraoxonase and coronary heart disease Atheroscler Suppl 3 49 55 12573363 10.1016/S1567-5688(02)00046-6 1:CAS:528:DC%2BD3sXotlCnsA%3D%3D (Pubitemid 38234486)
15. VG Cabana CA Reardon N Feng S Neath J Lukens GS Getz 2003 Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response J Lipid Res 44 780 792 12562837 10.1194/jlr.M200432-JLR200 1:CAS:528:DC%2BD3sXjtFCrtrk%3D (Pubitemid 37279680)
16. E Liberopoulos F Apostolou M Elisaf 2004 Serum lipid profile in patients with severe leptospirosis Nephrol Dial Transpl 19 1328 1329 10.1093/ndt/gfh054
17. AN Georgiadis EC Papavasiliou ES Lourida Y Alamanos C Kostara AD Tselepis, et al. 2006 Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment - a prospective, controlled study Arthritis Res Ther 8 R82 16646989 10.1186/ar1952
18. H Kusuoka JI Hoffman 2002 Advice on statistical analysis for circulation research Circ Res 91 662 671 12386142 10.1161/01.RES.0000037427.73184.C1 1:CAS:528:DC%2BD38Xnslaqtbg%3D (Pubitemid 35204948)
19. Khovidhunkit W, Memon RA, Feingold KR, Grunfeld C (2000) Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis 181(Suppl 3):S462-S472 (Pubitemid 30416122)
20. H Gierens M Nauck M Roth R Schinker C Schurmann H Scharnagl, et al. 2000 Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements Arterioscler Thromb Vasc Biol 20 1777 1783 10894816 10.1161/01.ATV.20.7.1777 1:CAS:528:DC%2BD3cXlsFGnsbc%3D (Pubitemid 30470593)
21. WH Ettinger VK Varma M Sorci-Thomas JS Parks RC Sigmon TK Smith, et al. 1994 Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells Arterioscler Thromb 14 8 13 8274481 10.1161/01.ATV.14.1.8 1:CAS:528: DyaK2cXisVaiurY%3D
22. J Ribalta JC Vallve J Girona L Masana 2003 Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease Curr Opin Clin Nutr Metab Care 6 177 187 12589187 10.1097/00075197-200303000-00006 1:CAS:528:DC%2BD3sXislaqu7s%3D (Pubitemid 40674521)
23. Mahley RW, Weisgraber KH, Huang Y (2009) Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J Lipid Res 50(Suppl):S183-S188
24. W Jin GS Sun D Marchadier E Octtaviani JM Glick DJ Rader 2003 Endothelial cells secrete triglyceride lipase and phospholipase activities in response to cytokines as a result of endothelial lipase Circ Res 92 644 650 12609972 10.1161/01.RES.0000064502.47539.6D 1:CAS:528:DC%2BD3sXitlKntr8%3D (Pubitemid 36417699)
25. H Ly OL Francone CJ Fielding JK Shigenaga AH Moser C Grunfeld, et al. 1995 Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters J Lipid Res 36 1254 1263 7666003 1:CAS:528:DyaK2MXms1CntbY%3D
26. HJ van Leeuwen AP van Beek GM Dallinga-Thie JA van Strijp J Verhoef KP van Kessel 2001 The role of high density lipoprotein in sepsis Neth J Med 59 102 110 11583825 10.1016/S0300-2977(01)00144-9 (Pubitemid 32907197)
27. V Mooser MM Berger L Tappy C Cayeux SM Marcovina R Darioli, et al. 2000 Major reduction in plasma Lp(a) levels during sepsis and burns Arterioscler Thromb Vasc Biol 20 1137 1142 10764684 10.1161/01.ATV.20.4.1137 1:CAS:528:DC%2BD3cXjtV2hsb8%3D (Pubitemid 30207593)
28. R Ramharack D Barkalow MA Spahr 1998 Dominant negative effect of TGF-beta1 and TNF-alpha on basal and IL-6-induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures Arterioscler Thromb Vasc Biol 18 984 990 9633941 10.1161/01.ATV.18.6.984 1:CAS:528:DyaK1cXktFagtL8%3D (Pubitemid 28272595)
29. SS Kilic S Aydin N Kilic F Erman S Aydin I Celik 2005 Serum arylesterase and paraoxonase activity in patients with chronic hepatitis World J Gastroenterol 11 7351 7354 16437641 1:CAS:528:DC%2BD28XhslWrsb0%3D (Pubitemid 43137689)
30. S Parra C Alonso-Villaverde B Coll N Ferre J Marsillach G Aragones, et al. 2007 Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection Atherosclerosis 194 175 181 16942773 10.1016/j.atherosclerosis.2006.07.024 1:CAS:528:DC%2BD2sXhtFWisbzL (Pubitemid 47464297)
31. M Aslan Y Nazligul M Horoz C Bolukbas FF Bolukbas M Gur, et al. 2008 Serum paraoxonase-1 activity in Helicobacter pylori infected subjects Atherosclerosis 196 270 274 17125774 10.1016/j.atherosclerosis.2006.10.024 1:CAS:528:DC%2BD1cXpt12jsw%3D%3D
32. HS Akbas S Basyigit I Suleymanlar D Kemaloglu S Koc F Davran, et al. 2010 The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects Lipids Health Dis 9 92 20804546 10.1186/1476-511X-9-92
33. Feingold KR, Hardardottir I, Grunfeld C (1998) Beneficial effects of cytokine induced hyperlipidemia. Z Ernährungswiss 37(Suppl 1):66-74
34. S Endo K Inada H Yamashita T Takakuwa H Nakae T Kasai, et al. 1994 Platelet-activating factor (PAF) acetylhydrolase activity, type II phospholipase A2, and cytokine levels in patients with sepsis Res Commun Chem Pathol Pharmacol 83 289 295 8008978 1:STN:280:DyaK2c3nvVagsA%3D%3D
35. T Takakuwa S Endo H Nakae T Suzuki K Inada M Yoshida, et al. 1994 Relationships between plasma levels of type-II phospholipase A2, PAF-acetylhydrolase, leukotriene B4, complements, endothelin-1, and thrombomodulin in patients with sepsis Res Commun Chem Pathol Pharmacol 84 271 281 7938901 1:CAS:528:DyaK2cXksl2qtrw%3D
36. K Karasawa A Harada N Satoh K Inoue M Setaka 2003 Plasma platelet activating factor-acetylhydrolase (PAF-AH) Prog Lipid Res 42 93 114 12547653 10.1016/S0163-7827(02)00049-8 1:CAS:528:DC%2BD3sXltVKntg%3D%3D (Pubitemid 36120431)
37. RM Graham CJ Stephens W Silvester LL Leong MJ Sturm RR Taylor 1994 Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis Crit Care Med 22 204 212 8306677 10.1097/00003246-199402000- 00009 1:STN:280:DyaK2c7jvFehuw%3D%3D (Pubitemid 24061641)
38. KM Howard MS Olson 2000 The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats J Biol Chem 275 19891 19896 10748027 10.1074/jbc.M001462200 1:CAS:528:DC%2BD3cXkslahtbs%3D (Pubitemid 30441593)
39. BJ Van Lenten SY Hama FC de Beer DM Stafforini TM McIntyre SM Prescott, et al. 1995 Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures J Clin Invest 96 2758 2767 8675645 10.1172/JCI118345
40. BJ Van Lenten AC Wagner DP Nayak S Hama M Navab AM Fogelman 2001 High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection Circulation 103 2283 2288 11342478 (Pubitemid 32433719)
41. J Yang Y Zhang J Xu Y Geng X Chen H Yang, et al. 2009 Serum activity of platelet-activating factor acetylhydrolase is a potential clinical marker for leptospirosis pulmonary hemorrhage PLoS One 4 e4181 19145243 10.1371/journal.pone.0004181
42. H Narahara JM Johnston 1993 Effects of endotoxins and cytokines on the secretion of platelet-activating factor-acetylhydrolase by human decidual macrophages Am J Obstet Gynecol 169 531 537 8372856 1:CAS:528:DyaK3sXmt1eqs7k%3D (Pubitemid 23290161)
43. J Kim HH Park I Choi YO Kim KH Cho 2010 Severely modified lipoprotein properties without a change in cholesteryl ester transfer protein activity in patients with acute renal failure secondary to Hantaan virus infection BMB Rep 43 535 540 20797315 10.5483/BMBRep.2010.43.8.535 1:CAS:528:DC%2BC3cXht1Wgt7nK
44. P Wiesen L Van Overmeire P Delanaye B Dubois JC Preiser 2011 Nutrition disorders during acute renal failure and renal replacement therapy JPEN J Parenter Enteral Nutr 35 217 222 21378251 10.1177/0148607110377205